- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
COVID-19 Topics and More Featured at CHEST 2021
Compared with conferences held a year ago at this time, when vaccines were not yet available and the United States had yet to hit the peak of the pandemic, there are now more data to discuss about what we know and do not know about COVID-19.
The CHEST 2021 Annual Meeting kicks off Sunday in a virtual environment, having had to make the switch from a hybrid setting due to the continuing pandemic.
Compared with conferences held a year ago at this time, when vaccines were not yet available and the United States had yet to hit the peak of the pandemic, there are now more data to discuss about what we know and do not know about COVID-19, long-term outcomes, vaccines, and other related issues.
More than 2 dozen presentations delve into COVID-19’s impact across health care, including sleep medicine, palliative care, intensive care units, lung cancer, pulmonary disorders, health equity, and more.
The keynote address, called “Perseverance and Motivation: Empathetic Medicine Amidst COVID and Beyond,” will be given by Demondes Haynes, MD, FCCP, the associate dean for admissions for the School of Medicine at the University of Mississippi Medical Center, where he is a professor of medicine in the Division of Pulmonary, Critical Care, and Sleep Medicine.
Mississippi is the state with the worst outcomes from COVID-19, from number of deaths to a doubling of the stillborn rate since the start of the pandemic. State officials recently pleaded with pregnant women there to get vaccinated, and the governor this week extended the state of emergency.
Other hot topics include issues in critical care, sepsis, acute respiratory distress syndrome, sleep medicine, asthma, chronic obstructive pulmonary disease, lung cancer, vaping, and more.
Abstracts linked with the meeting are published in an October 2021 supplement to Chest.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More
